Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 2];10(2):s728. Available from: https://skin.dermsquared.com/skin/article/view/4041